Cargando…
A review of the changes to the licensing of influenza vaccines in Europe
In 2014, the European Committee for Medicinal Products for Human Use (CHMP) published a draft regulatory guideline for the evaluation of influenza vaccines. Following a public consultation round, the final guidance will be published in the near future. Here, we highlight the main changes in the clin...
Autores principales: | Wijnans, Leonoor, Voordouw, Bettie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4687503/ https://www.ncbi.nlm.nih.gov/pubmed/26439108 http://dx.doi.org/10.1111/irv.12351 |
Ejemplares similares
-
Effectiveness of MF59™ Adjuvanted Influenza A(H1N1)pdm09 Vaccine in Risk Groups in the Netherlands
por: Wijnans, Leonoor, et al.
Publicado: (2013) -
An overview of the regulation of influenza vaccines in the United States
por: Weir, Jerry P., et al.
Publicado: (2016) -
Standardisation of inactivated influenza vaccines—Learning from history
por: Wood, John M., et al.
Publicado: (2018) -
The hidden burden of influenza: A review of the extra‐pulmonary complications of influenza infection
por: Sellers, Subhashini A., et al.
Publicado: (2017) -
Bell’s palsy and influenza(H1N1)pdm09 containing vaccines: A self-controlled case series
por: Wijnans, Leonoor, et al.
Publicado: (2017)